Russell Investments Group’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.1M | Buy |
16,301
+3,013
| +23% | +$183K | ﹤0.01% | 2415 |
|
|
2026
Q1 | $737K | Sell |
13,288
-6,426
| -33% | -$346K | ﹤0.01% | 2353 |
|
|
2025
Q4 | $956K | Sell |
19,714
-14,318
| -42% | -$558K | ﹤0.01% | 2236 |
|
|
2025
Q3 | $1.04M | Buy |
34,032
+10,241
| +43% | +$235K | ﹤0.01% | 2197 |
|
|
2025
Q2 | $528K | Buy |
+23,791
| New | +$498K | ﹤0.01% | 2318 |
|
|
2025
Q1 | – | Sell |
-5,698
| Closed | -$75.4K | – | 3794 |
|
|
2024
Q4 | $75.4K | Buy |
5,698
+5,360
| +1,586% | +$130K | ﹤0.01% | 2738 |
|
|
2024
Q3 | $11.3K | Sell |
338
-5,452
| -94% | -$186K | ﹤0.01% | 3052 |
|
|
2024
Q2 | $145K | Sell |
5,790
-2,357
| -29% | -$54.9K | ﹤0.01% | 2548 |
|
|
2024
Q1 | $183K | Sell |
8,147
-390
| -5% | -$9.23K | ﹤0.01% | 2458 |
|
|
2023
Q4 | $183K | Sell |
8,537
-7,663
| -47% | -$132K | ﹤0.01% | 2447 |
|
|
2023
Q3 | $291K | Sell |
16,200
-908
| -5% | -$17.3K | ﹤0.01% | 2400 |
|
|
2023
Q2 | $348K | Buy |
17,108
+216
| +1% | +$4.38K | ﹤0.01% | 2335 |
|
|
2023
Q1 | $368K | Buy |
16,892
+15,874
| +1,559% | +$386K | ﹤0.01% | 2350 |
|
|
2022
Q4 | $31.5K | Hold |
1,018
| – | – | ﹤0.01% | 2766 |
|
|
2022
Q3 | $25K | Sell |
1,018
-16,224
| -94% | -$380K | ﹤0.01% | 2793 |
|
|
2022
Q2 | $349K | Buy |
17,242
+45
| +0.3% | +$997 | ﹤0.01% | 2382 |
|
|
2022
Q1 | $424K | Sell |
17,197
-721
| -4% | -$21.8K | ﹤0.01% | 2276 |
|
|
2021
Q4 | $621K | Sell |
17,918
-471
| -3% | -$14.9K | ﹤0.01% | 2359 |
|
|
2021
Q3 | $497K | Buy |
18,389
+588
| +3% | +$14.9K | ﹤0.01% | 2463 |
|
|
2021
Q2 | $460K | Hold |
17,801
| – | – | ﹤0.01% | 2624 |
|
|
2021
Q1 | $381K | Sell |
17,801
-2,805
| -14% | -$70.8K | ﹤0.01% | 2626 |
|
|
2020
Q4 | $443K | Sell |
20,606
-20,396
| -50% | -$495K | ﹤0.01% | 2474 |
|
|
2020
Q3 | $602K | Buy |
41,002
+18,170
| +80% | +$328K | ﹤0.01% | 2310 |
|
|
2020
Q2 | $509K | Sell |
22,832
-19,741
| -46% | -$361K | ﹤0.01% | 2375 |
|
|
2020
Q1 | $600K | Sell |
42,573
-3,354
| -7% | -$50.9K | ﹤0.01% | 2099 |
|
|
2019
Q4 | $745K | Buy |
45,927
+24,310
| +112% | +$575K | ﹤0.01% | 2250 |
|
|
2019
Q3 | $757K | Buy |
21,617
+5,609
| +35% | +$267K | ﹤0.01% | 2132 |
|
|
2019
Q2 | $903K | Hold |
16,008
| – | – | ﹤0.01% | 2027 |
|
|
2019
Q1 | $1.17M | Hold |
16,008
| – | – | ﹤0.01% | 1988 |
|
|
2018
Q4 | $1.02M | Sell |
16,008
-2,144
| -12% | -$159K | ﹤0.01% | 1943 |
|
|
2018
Q3 | $1.81M | Buy |
18,152
+2,254
| +14% | +$187K | ﹤0.01% | 1805 |
|
|
2018
Q2 | $1.13M | Sell |
15,898
-30
| -0.2% | -$2.52K | ﹤0.01% | 2056 |
|
|
2018
Q1 | $1.66M | Buy |
15,928
+13,399
| +530% | +$1.51M | ﹤0.01% | 1961 |
|
|
2017
Q4 | $254K | Buy |
+2,529
| New | +$186K | ﹤0.01% | 2611 |
|
Other funds holding ANAB
EC
TCM
AAA
S
WP
6CM
Russell Investments Group's ANAB Position: Q2 2026 in Review
Russell Investments Group increased its AnaptysBio (ANAB) stake by 23% in Q2 2026, buying an estimated $183K and bringing the position to 16,301 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2415.
Russell Investments Group first reported a position in ANAB in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.81M in Q3 2018. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.
- Russell Investments Group held 16,301 shares of AnaptysBio worth $1.1M as of Q2 2026.
- Russell Investments Group bought 3,013 AnaptysBio shares in Q2 2026, an estimated $183K.
- AnaptysBio made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2415 holding.
- Russell Investments Group first reported a position in AnaptysBio in Q4 2017 and has held it in 34 quarters since.
- Russell Investments Group's AnaptysBio position peaked at $1.81M in Q3 2018.
- 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.